Drug Type Synthetic peptide |
Synonyms + [1] |
Target |
Action modulators, blockers |
Mechanism PI3K family modulators(Phosphatidylinositol 3-kinase family modulators), chloride channel blockers(Chloride channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 1 | United States | 01 Feb 2008 | |
Oligodendroglioma | Phase 1 | United States | 01 Feb 2008 | |
Recurrent Malignant Glioma | Phase 1 | United States | 01 Feb 2008 | |
Recurrent Glioblastoma | Preclinical | United States | 15 Apr 2006 | |
Recurrent Glioblastoma | Preclinical | United States | 15 Apr 2006 |
Not Applicable | - | jvqdnztxzd(lfuhqhxslj) = hreoblcplf mgflfpwdof (yykxhkrnhl ) | - | 01 Apr 2009 |